End-of-day quote
Johannesburg S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
53.12
ZAR
|
-0.71%
|
|
-7.47%
|
-18.74%
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,461
|
3,878
|
12,287
|
9,151
|
8,563
|
-
|
-
|
Enterprise Value (EV)
1 |
7,864
|
3,878
|
12,287
|
7,817
|
6,297
|
5,972
|
5,604
|
P/E ratio
|
-
|
23.1
x
|
9.32
x
|
8.12
x
|
7.44
x
|
6.04
x
|
5.18
x
|
Yield
|
1.47%
|
-
|
-
|
6.67%
|
6.73%
|
7.44%
|
7.91%
|
Capitalization / Revenue
|
0.19
x
|
0.21
x
|
-
|
0.34
x
|
0.4
x
|
0.38
x
|
0.36
x
|
EV / Revenue
|
0.42
x
|
0.21
x
|
-
|
0.29
x
|
0.29
x
|
0.26
x
|
0.23
x
|
EV / EBITDA
|
8
x
|
2.07
x
|
-
|
3.04
x
|
2.64
x
|
2.11
x
|
1.76
x
|
EV / FCF
|
-
|
3.73
x
|
-
|
4.17
x
|
2.96
x
|
6.34
x
|
4.88
x
|
FCF Yield
|
-
|
26.8%
|
-
|
24%
|
33.7%
|
15.8%
|
20.5%
|
Price to Book
|
0.49
x
|
-
|
-
|
0.88
x
|
0.82
x
|
0.78
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
68,003
|
169,576
|
163,386
|
162,832
|
161,192
|
-
|
-
|
Reference price
2 |
50.90
|
22.87
|
75.20
|
56.20
|
53.12
|
53.12
|
53.12
|
Announcement Date
|
6/25/19
|
7/7/20
|
6/20/22
|
6/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,628
|
18,737
|
-
|
26,572
|
21,450
|
22,740
|
23,971
|
EBITDA
1 |
982.8
|
1,872
|
-
|
2,573
|
2,388
|
2,825
|
3,178
|
EBIT
1 |
367.8
|
947.9
|
-
|
1,899
|
1,684
|
2,151
|
2,496
|
Operating Margin
|
1.97%
|
5.06%
|
-
|
7.15%
|
7.85%
|
9.46%
|
10.41%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
1,818
|
1,690
|
2,132
|
2,466
|
Net income
|
-
|
124
|
1,356
|
1,152
|
-
|
-
|
-
|
Net margin
|
-
|
0.66%
|
-
|
4.34%
|
-
|
-
|
-
|
EPS
2 |
-
|
0.9900
|
8.070
|
6.920
|
7.140
|
8.800
|
10.26
|
Free Cash Flow
1 |
-
|
1,040
|
-
|
1,873
|
2,124
|
942
|
1,149
|
FCF margin
|
-
|
5.55%
|
-
|
7.05%
|
9.9%
|
4.14%
|
4.79%
|
FCF Conversion (EBITDA)
|
-
|
55.56%
|
-
|
72.79%
|
88.94%
|
33.35%
|
36.15%
|
FCF Conversion (Net income)
|
-
|
838.71%
|
-
|
162.59%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.7500
|
-
|
-
|
3.750
|
3.575
|
3.950
|
4.200
|
Announcement Date
|
6/25/19
|
7/7/20
|
6/20/22
|
6/19/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
4,403
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
1,334
|
2,266
|
2,591
|
2,959
|
Leverage (Debt/EBITDA)
|
4.48
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
1,040
|
-
|
1,873
|
2,124
|
942
|
1,149
|
ROE (net income / shareholders' equity)
|
-5.67%
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
8%
|
7%
|
7%
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
105.0
|
-
|
-
|
63.70
|
64.80
|
67.90
|
71.30
|
Cash Flow per Share
|
7.930
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1,120
|
514
|
-
|
396
|
700
|
550
|
578
|
Capex / Sales
|
6.01%
|
2.74%
|
-
|
1.49%
|
3.26%
|
2.42%
|
2.41%
|
Announcement Date
|
6/25/19
|
7/7/20
|
6/20/22
|
6/19/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -18.74% | 455M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|